Company / Operating Cash Flow
Pediatrix Medical Group Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$271.1M
FY2025
5-year range
$76.7M / $271.1M
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
#74 of 164
Health Care
What the data says
At $271M, Pediatrix Medical Group's operating cash flow ranks #74 of 164 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from $77M in FY2021 to $511M in FY2017.
Based on SEC 10-K filings.
$271M in FY2025 with a 5-year CAGR of +5.8%.
Improved from $137M to $271M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +17.5%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
#74 of 164 in Health CareTop 45% of 164This company $271.1M Sector average $1.0B
▼
-74.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, operating cash flow increased 31.2% year-over-year.
- Ranks #74 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.65 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $271.1M | +31.2% |
| FY2024 | $206.6M | +50.4% |
| FY2023 | $137.3M | -17.7% |
| FY2022 | $166.9M | +117.5% |
| FY2021 | $76.7M | -62.5% |
| FY2020 | $204.6M | -42.8% |
| FY2019 | $357.7M | +14.0% |
| FY2018 | $313.7M | -38.7% |
| FY2017 | $511.4M | +15.2% |
| FY2016 | $443.8M | +20.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026